Faculty
Faculty Advisors, Title, Primary Appointment (Joint Appointment) — Cardiovascular Disease Interests
Josef Coresh, (PI) MD, PhD, Program Director — Cardiovascular and kidney disease, epidemiologic methods, genetic epidemiology
Elizabeth Selvin, PhD, MPH, Program Co-Director— Cardiovascular disease and diabetes, epidemiologic methods, biomarkers of diabetes and hyperglycemia
Shoshana H. Ballew, PhD, Assistant Program Director— Aging, caregiving, epidemiology, chronic kidney disease, cardiovascular disease
Lawrence J. Appel, MD, MPH — Blood pressure-related cardiovascular and kidney diseases, nutrition
Terri H. Beaty, MA, PhD — Use of statistical genetics to identify genetic factors contributing to risk of chronic diseases
Michael J. Blaha, MD, MPH — Primary Prevention of Heart Disease and Stroke; Advanced Subclinical Atherosclerosis
Lorraine T. Dean, ScD — Social determinants, cancer survivorship, HIV/AIDS, disparities
Mara M. DeMarco, PhD — Epidemiology of aging, end stage renal disease, pharmacoepidemiology, gout
Rebecca Gottesman, MD, PhD — Improving functional outcome scales after stroke epidemiology and clinical research. Vascular basis of dementia. Neurological aspects of CVD and development of stroke after cardiac surgery
Morgan Grams, MD — Chronic kidney disease, pharmacoepidemiology, omics studies
Eliseo Guallar, MD, DrPH — Cardiovascular epidemiology, with a special emphasis on Environmental exposures such as heavy metals. Epidemiologic methods especially meta-analysis
John W. Jackson, ScD — Causal inference, confounding, decomposition, epidemiology, health disparities, instrumental variable, interaction, intersectionality, mediation-analysis, mental health, meta-analysis, pharmacoepidemiology, psychotropics, diagnostics, observational-study, time-varying exposure, translational research, transparency
Seth S. Martin, MD, MHS — Cardiovascular Risk Assessment, Dyslipidemia, Mobile Health Technology, Primary and secondary prevention of coronary heart disease, Individuals with a family history of heart disease, Improved strategies for management of cardiovascular risk factors, Preventive Cardiology, Atherosclerosis Imaging, Lipids. Co-leads a Strategically Focused Health Technologies & Innovation Research Network Award funded by the AHA and the Center for Health Technology and Innovation.
Kunihiro Matsushita, MD, PhD — Cardiovascular disease epidemiology, especially heart failure, peripheral arterial disease, chronic kidney disease. Meta-analysis and risk prediction methods
Erin D. Michos, MD, MHS, FACC, FAHA — Women and heart disease, vitamin D and cardiovascular health, preventive cardiology, subclinical atherosclerosis imaging, sex hormones and cardiovascular disease
Noel T. Mueller, PhD, MPH, FAHA — Epidemiology, nutrition, microbiome, obesity, type 2 diabetes, non-alcoholic fatty liver disease
Chiadi E. Ndumele, MD, MHS, PhD - Obesity and its metabolic and cardiovascular consequences. Co-leads a Strategically Focused Cardiometabolic Health & Type 2 Diabetes Mellitus Research Network – Award from AHA.
Wendy Post, MD — Risk prediction, cardiovascular disease in HIV, subclinical atherosclerosis imaging, genetic epidemiology
Tanjala S. Purnell, PhD, MPH — Improved equity in access to kidney transplantation, reduced disparities in kidney disease burden and outcomes, patient-centered care for kidney disease and risk factors, including hypertension and diabetes, community and stakeholder-engaged interventions
Debashree Ray, PhD — Case-control study, external controls, Genome-wide association study (GWAS), lipids, meta-analysis, multiple traits, multivariate analysis, overlapping samples, secondary traits, statistical genetics, statistical methods, trio study design, type II diabetes
Casey M. Rebholz, PhD — Biomarkers, kidney disease, cardiovascular disease, nutritional epidemiology
Jennifer A. Schrack, PhD — Epidemiological assessment of physical activity and fatigability, and their corresponding associations with health and longevity in older populations